Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Eli Lilly and Boehringer Ingelheim launch first GCC activity since the announcement of their global strategic alliance in 2011
Dubai, UAE, 23 February 2013: More than 200 endocrinologists and healthcare professionals specialized in diabetes care gathered on Friday 22 February 2013. The scientific meeting, hosted by two specialists in diabetes treatment and research, Boehringer Ingelheim and Eli Lilly included a presentation by both companies summarizing the impacts on and benefits for diabetes patients in the region resulting from their 20-year strategic alliance cemented in early 2011. The event coincided with the announcement of the launch and commercialization in the UAE of the first treatment emerging from the alliance, a once daily oral treatment for Type 2 diabetes patients.
The prevalence of type 2 diabetes is growing not just because the world's population is expanding and getting older, but also because obesity is on the rise across the globe. More people are being affected and at a younger age. According to the latest figures from the International Diabetes Federation released on December 2012 (IDF Atlas- 5th Edition- 2012 update), four Gulf nations - Kuwait, Saudi Arabia, Qatar and Bahrain - rank among the top ten counties globally for prevalence of diabetes among adults aged 20-79 years, with the UAE ranked 11th. An estimated one in five adults in the Gulf has diabetes, and across the Middle East it is estimated that half of those people with diabetes do not know that they have the disease (IDF Atlas- 5th Edition- 2012 update).
http://www.zawya.com/story/Alliance...erts_from_across_the_UAE-ZAWYA20130223100242/
Dubai, UAE, 23 February 2013: More than 200 endocrinologists and healthcare professionals specialized in diabetes care gathered on Friday 22 February 2013. The scientific meeting, hosted by two specialists in diabetes treatment and research, Boehringer Ingelheim and Eli Lilly included a presentation by both companies summarizing the impacts on and benefits for diabetes patients in the region resulting from their 20-year strategic alliance cemented in early 2011. The event coincided with the announcement of the launch and commercialization in the UAE of the first treatment emerging from the alliance, a once daily oral treatment for Type 2 diabetes patients.
The prevalence of type 2 diabetes is growing not just because the world's population is expanding and getting older, but also because obesity is on the rise across the globe. More people are being affected and at a younger age. According to the latest figures from the International Diabetes Federation released on December 2012 (IDF Atlas- 5th Edition- 2012 update), four Gulf nations - Kuwait, Saudi Arabia, Qatar and Bahrain - rank among the top ten counties globally for prevalence of diabetes among adults aged 20-79 years, with the UAE ranked 11th. An estimated one in five adults in the Gulf has diabetes, and across the Middle East it is estimated that half of those people with diabetes do not know that they have the disease (IDF Atlas- 5th Edition- 2012 update).
http://www.zawya.com/story/Alliance...erts_from_across_the_UAE-ZAWYA20130223100242/